{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:53:45Z","timestamp":1787496825569,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.dld.2013.06.010","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T04:15:51Z","timestamp":1375848951000},"page":"969-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Definition and evaluation of mucosal healing in clinical practice"],"prefix":"10.1016","volume":"45","author":[{"given":"Silvia","family":"Mazzuoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco W.","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Salemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrio","family":"Bassotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2013.06.010_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/gut.2005.088732","article-title":"Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target","volume":"56","author":"Rutgeerts","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2036.2010.04575.x","article-title":"Randomised clinical trial: delayed-release oral mesalazine 4.8g\/day vs. 2.4g\/day in endoscopic mucosal healing\u2014ASCEND I and II combined analysis","volume":"33","author":"Lichtenstein","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0016-5107(99)80017-0","article-title":"Endoscopic and histologic healing of Crohn's ileo-colitis with azathioprine","volume":"50","author":"D\u2019Haens","year":"1999","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2036.2007.03361.x","article-title":"MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials","volume":"26","author":"Sandborn","year":"2007","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2010.12.028","article-title":"Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis","volume":"9","author":"Ardizzone","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0040","doi-asserted-by":"crossref","first-page":"947e53","DOI":"10.1002\/ibd.21439","article-title":"Endoscopic monitoring of infliximab therapy in Crohn's disease","volume":"17","author":"af Bjorkesten","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.01.035","article-title":"Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial","volume":"142","author":"Rutgeerts","year":"2012","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.dld.2013.06.010_bib0050","first-page":"G970","article-title":"Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF on tight junctions and signaling pathways in intestinal epithelial cells","volume":"304","author":"Fischer","year":"2013","journal-title":"American Journal of Physiology: Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.dld.2013.06.010_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","article-title":"Clinical Implications of mucosal healing for the management of IBD","volume":"7","author":"De Chambrun","year":"2010","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrgastro.2009.203","article-title":"Clinical implications of mucosal healing for the management of IBD","volume":"7","author":"Pineton de Chambrun","year":"2010","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2174\/138945011796818216","article-title":"Mucosal healing in ulcerative colitis: where do we stand?","volume":"12","author":"Fiorino","year":"2011","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.dld.2013.06.010_bib0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis","volume":"132","author":"D\u2019Haens","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","article-title":"A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with Crohn's disease","volume":"122","author":"William","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0080","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ibd.21034","article-title":"Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease","volume":"15","author":"D\u2019Haens","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2013.06.010_bib0085","first-page":"A15","article-title":"Mucosal healing after initial treatment may be a prognostic marker for long-term outcome in inflammatory bowel disease","volume":"57","author":"Solberg","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0090","first-page":"100A","article-title":"Endoscopic healing after infliximab treatment for Crohn's disease provides a longer time to relapse","volume":"122","author":"D\u2019Haens","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0095","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ibd.20927","article-title":"Mucosal healing predicts long term outcome of maintenance therapy with infliximab in Crohn's disease","volume":"15","author":"Schnitzler","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Vatn Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"33","author":"Froslie","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MEG.0b013e32835414b2","article-title":"Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease","volume":"24","author":"Casellas","year":"2012","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0110","doi-asserted-by":"crossref","first-page":"6e9","DOI":"10.2174\/187152810791292863","article-title":"Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast","volume":"9","author":"Actis","year":"2010","journal-title":"Inflammation & Allergy Drug Targets"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2013.06.010_bib0115","first-page":"3","article-title":"Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies","volume":"24","author":"Magro","year":"2010","journal-title":"Bio Drugs"},{"key":"10.1016\/j.dld.2013.06.010_bib0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.crohns.2011.06.009","article-title":"Results from the 2nd Scientific Workshop of the ECCO (I): impact of mucosal healing on the course of inflammatory bowel disease","volume":"5","author":"Peyrin-Biroulet","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.dld.2013.06.010_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-3565(04)00441-0","article-title":"Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice","volume":"3","author":"David","year":"2005","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0130","first-page":"1038","article-title":"Ultrastructural abnormalities in endoscopically and histologically normal and involved colon in ulcerative colitis","volume":"84","author":"Delpre","year":"1989","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0135","first-page":"867e72","article-title":"Prospective evaluation of the learning curve of confocal laser endomicroscopy in patients with IBD","volume":"26","author":"Neumann","year":"2011","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.dld.2013.06.010_bib0140","doi-asserted-by":"crossref","first-page":"63e8","DOI":"10.3748\/wjg.v17.i1.63","article-title":"New endoscopic approaches in IBD","volume":"17","author":"Neumann","year":"2011","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0145","doi-asserted-by":"crossref","first-page":"874e82","DOI":"10.1053\/j.gastro.2007.01.048","article-title":"Chromoscopyguided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis","volume":"132","author":"Kiesslich","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.dld.2013.06.010_bib0150","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/ajg.2009.664","article-title":"Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy","volume":"105","author":"Li","year":"2010","journal-title":"American Journal of Gastroenterology"},{"issue":"S2","key":"10.1016\/j.dld.2013.06.010_bib0155","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1111\/j.1440-1746.2008.05559.x","article-title":"Confocal endomicroscopy in patients with ulcerative colitis","volume":"23","author":"Watanabe","year":"2008","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00384-008-0631-9","article-title":"Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation","volume":"24","author":"Kudo","year":"2009","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2013.06.010_bib0165","doi-asserted-by":"crossref","first-page":"525098","DOI":"10.1155\/2012\/525098","article-title":"Confocal laser endomicroscopy in the Study of Colonic Mucosa in IBD Patients: a review","volume":"2012","author":"Salvatori","year":"2012","journal-title":"Gastroenterology Research and Practice"},{"key":"10.1016\/j.dld.2013.06.010_bib0170","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gut.2005.086900","article-title":"Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis","volume":"55","author":"Nishio","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2013.06.010_bib0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0016-5107(02)70439-2","article-title":"Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis","volume":"56","author":"Fujiya","year":"2002","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0180","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.gie.2007.04.014","article-title":"Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study","volume":"66","author":"Matsumoto","year":"2007","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0185","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MEG.0b013e32834791b4","article-title":"Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy","volume":"23","author":"Hlavaty","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0190","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/gut.2007.144097","article-title":"Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomized comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions","volume":"57","author":"van den Broek","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/ibd.22907","article-title":"Assessment of Crohn's disease activity by confocal laser endomicroscopy","author":"Neumann","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0200","doi-asserted-by":"crossref","first-page":"114653","DOI":"10.1136\/gutjnl-2011-300695","article-title":"Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease","volume":"61","author":"Kiesslich","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0210","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0029-1214790","article-title":"Role of small bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus","volume":"41","author":"Bourreille","year":"2009","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0215","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicenter study. Groupe d\u2019Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0220","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2036.2006.03056.x","article-title":"Review article: recurrence of Crohn's disease after surgery\u2013the need for treatment of new lesions","volume":"24","author":"Rutgeerts","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0230","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn's disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0235","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.25.6.665","article-title":"Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery","volume":"25","author":"Rutgeerts","year":"2004","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2013.06.010_bib0240","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situation","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2013.06.010_bib0245","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1002\/ibd.20655","article-title":"What is the role of endoscopy in the postoperative management of Crohn's disease?","volume":"14","author":"Rutgeerts","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0250","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ibd.21506","article-title":"Development of the Crohn's disease digestive damage score, the L\u00e9mann score","volume":"17","author":"Pariente","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0255","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2013.06.010_bib0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in proctocolitis","volume":"1","author":"Baron","year":"1964","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2013.06.010_bib0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/00365527809182199","article-title":"A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis","volume":"13","author":"Powell-Tuck","year":"1978","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0270","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","article-title":"5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis","volume":"92","author":"Sutherland","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of ulcerative colitis: randomized trials","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2013.06.010_bib0280","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","article-title":"Ulcerative Colitis: correlation of the Rachmilewitz Endoscopic Activity Index with fecal calprotectin, clinical activity, C-reactive protein and blood leukocytes","volume":"15","author":"Schoepfer","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0285","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomizes study","volume":"317","author":"Schroeder","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2013.06.010_bib0290","doi-asserted-by":"crossref","first-page":"A851","DOI":"10.1016\/S0016-5085(11)60567-2","article-title":"Validation of the ulcerative colitis endoscopic index of severity (UCEIS) and its correlation with clinical indices and laboratory measures of disease activity","volume":"140","author":"Samuel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cgh.2012.08.003","article-title":"Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures","volume":"11","author":"Samuel","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4321\/S1130-01082011000700006","article-title":"Non-IBD colitides: clinically useful histopathological clues","volume":"103","author":"Villanacci","year":"2011","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"10.1016\/j.dld.2013.06.010_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2007.11.001","article-title":"Warren BF; for the European Crohn's and Colitis Organization (ECCO). European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis","volume":"2","author":"Stange","year":"2008","journal-title":"Journal of Crohns and Colitis"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2013.06.010_bib0310","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"issue":"Suppl. 3","key":"10.1016\/j.dld.2013.06.010_bib0315","first-page":"III37","article-title":"Influence of treatment on morphological features of mucosal inflammation","volume":"50","author":"Geboes","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jcp.50.2.93","article-title":"Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative","volume":"50","author":"Jenkins","year":"1997","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.dld.2013.06.010_bib0325","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/gut.32.12.1514","article-title":"Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications","volume":"32","author":"Seldenrijk","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0330","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529409094843","article-title":"A prospective study of first attacks of inflammatory bowel disease and infectious colitis","volume":"29","author":"Schumacher","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"Bitton","year":"2001","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.dld.2013.06.010_bib0340","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0345","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jcgh.2003.50006","article-title":"The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine","volume":"1","author":"Kruis","year":"2003","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.06.010_bib0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.2002.01151.x","article-title":"A double-blind comparison of balsalazide, 6.75g, and sulfasalazine, 3g, as sole therapy in the management of ulcerative colitis","volume":"16","author":"Mansfield","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0355","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/gut.2008.154302","article-title":"International Salofalk OD Study Group Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomized, non-inferiority trial","volume":"58","author":"Kruis","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.MIB.0000158386.25660.1e","article-title":"A new oral delivery system for 5-ASA: preliminary clinical findings for MMx","volume":"11","author":"Prantera","year":"2005","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0365","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/00365528708991491","article-title":"Histologic and colonoscopic assessment of disease extension in ulcerative colitis","volume":"22","author":"Floren","year":"1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2036.2002.01199.x","article-title":"A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis","volume":"16","author":"Malchow","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0375","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/gut.38.2.229","article-title":"A randomized trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis","volume":"38","author":"Lee","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.06.010_bib0380","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.mib.0000231495.92013.5e","article-title":"Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials","volume":"12","author":"Regueiro","year":"2006","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0385","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","article-title":"Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium. A report on a controlled therapeutic trial","volume":"2","author":"Truelove","year":"1958","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2013.06.010_bib0390","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/0016-5085(95)90747-5","article-title":"An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease","volume":"109","author":"Sandborn","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0395","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0016-5085(97)70027-1","article-title":"Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease","volume":"112","author":"D\u2019Haens","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0400","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0016-5107(99)80017-0","article-title":"Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine","volume":"50","author":"D\u2019Haens","year":"1999","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2013.06.010_bib0405","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions caused by infusion of intestinal contents in excluded ileum in Crohn's disease","volume":"114","author":"D\u2019Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0410","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","article-title":"Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease","volume":"15","author":"Mantzaris","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0415","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2013.06.010_bib0420","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2036.2010.04569.x","article-title":"Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab","volume":"33","author":"Laharie","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.06.010_bib0425","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial","volume":"116","author":"D\u2019Haens","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","article-title":"Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis","volume":"116","author":"Baert","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0435","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1111\/j.1572-0241.2001.04705.x","article-title":"Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial","volume":"96","author":"D\u2019Haens","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.06.010_bib0440","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.dld.2007.06.003","article-title":"Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab","volume":"39","author":"Hassan","year":"2007","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2013.06.010_bib0445","first-page":"147","article-title":"Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis","volume":"19","author":"Fratila","year":"2010","journal-title":"Journal of Gastrointestinal and Liver Diseases"},{"key":"10.1016\/j.dld.2013.06.010_bib0450","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3748\/wjg.v19.i7.968","article-title":"Histological healing in inflammatory bowel disease: a still unfulfilled promise","volume":"19","author":"Villanacci","year":"2013","journal-title":"World Journal of Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813002247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813002247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T09:57:52Z","timestamp":1563616672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865813002247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1590865813002247"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2013.06.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definition and evaluation of mucosal healing in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2013.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}